Cargando…
Medico-Legal Aspects of Using Tissue Plasminogen Activator in Acute Ischemic Stroke
Intravenous alteplase or tissue plasminogen activator (tPA) has been the standard of care with proven efficacy for acute ischemic stroke for over a decade. Despite this, only a small fraction of potentially eligible stroke patients receive this medication. There seems to be a fear among practitioner...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Current Science Inc.
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085754/ https://www.ncbi.nlm.nih.gov/pubmed/21424751 http://dx.doi.org/10.1007/s11936-011-0122-0 |